Together, our preclinical mouse RCC model data from both genders (Fig 6A–C), are consistent and supported by results from the TCGA database showing RCC patients with higher ERβ expression had shorter overall survival and disease‐free survival. This evidence concerns the gene ESR2 and renal cell carcinoma.